In animal studies incorporating the use of transgenic AD rodent models, ω-3 FAs have been shown to have beneficial effects on Aβ pathology, tau pathology, and neuroinflammation [reviewed in Ref. The gene discussed is MAPT; the disease is Alzheimer disease.